Schröder R, Kowalski A, Jørgensen K. "一种的合成方法" [P]. European Patent, EP 3847694 A1, 2016-03-05.
Schröder R, Nowak P, Johansson L. "Method for the Synthesis of 1171552-34-3
3-Methyl-1-(3-nitropyridin-2-yl)piperazine hydrochloride
9817AC
C10H15ClN4O2" [P]. European Patent, EP 3665934 A1, 2016-11-12.
发明人郑宇鹏,杨光,郭海燕. "A Process for Preparing High-Purity 1171552-34-3
3-Methyl-1-(3-nitropyridin-2-yl)piperazine hydrochloride
9817AC
C10H15ClN4O2" [P]. 中国发明专利, 专利号 CN 114031791 A, 授权公告日 2020-01-13.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2013, 1172, (1), 8304-8315.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2025, 872, 7397-7402.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 1171552-34-3
3-Methyl-1-(3-nitropyridin-2-yl)piperazine hydrochloride
9817AC
C10H15ClN4O2 Using HRMS and NMR". J. Sep. Sci., 2010, 239, (7), 9410-9414.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2024, 1605, 4302-4311.